Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019)
Enanta Pharmaceuticals (ENTA) reported Capital Leases of $200000.0 for Q3 2019, down 31.74% on a YoY basis from $293000.0 in Q3 2018, and down 10.71% quarter-over-quarter from $224000.0 in Q2 2019.
Enanta Pharmaceuticals (ENTA) Capital Leases (2015 - 2019) Analysis & Trends
Enanta Pharmaceuticals has reported Capital Leases for 5 years, with the latest figure at $200000.0 in Q3 2019.
- For the quarter ending Q3 2019, Capital Leases fell 31.74% year-over-year to $200000.0; the trailing twelve-month figure through Sep 2019 stood at $200000.0 (down 31.74% YoY), and the FY2019 full-year result was $200000.0, down 31.74% from the prior year.
- Capital Leases for Q3 2019 stood at $200000.0, down from $224000.0 in the prior quarter.
- The five-year high for Capital Leases was $529000.0 in Q3 2015, with the low at $175000.0 in Q2 2015.
- Historically, Capital Leases has averaged $364166.7 across 5 years, with a median of $368500.0 in 2017.
- Annual changes were most pronounced in 2016 — Capital Leases soared 173.14% — and 2019, when it slumped 31.74%.
- Enanta Pharmaceuticals' Capital Leases stood at $513000.0 in 2015, then declined by 14.23% to $440000.0 in 2016, then dropped by 18.64% to $358000.0 in 2017, then dropped by 24.3% to $271000.0 in 2018, then slipped by 26.2% to $200000.0 in 2019.
- The last three Capital Leases figures came in at $200000.0 (Q3 2019), $224000.0 (Q2 2019), and $249000.0 (Q1 2019), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 814,307.08 Bn | 814,307.05 Bn | - |
| 2 | Belite Bio | 55,320.00 Bn | 55,320.00 Bn | - |
| 3 | Quantum Biopharma | 17,149.72 Bn | 17,149.72 Bn | - |
| 4 | Legend Biotech | 3,590.00 Bn | 3,589.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,650.72 Bn | 1,650.72 Bn | - |
| 6 | Evaxion A | 1,522.09 Bn | 1,522.07 Bn | - |
| 7 | Psyence Biomedical | 229.39 Bn | 229.38 Bn | - |
| 8 | Vertex Pharmaceuticals | 113.09 Bn | 105.85 Bn | 2.59 Bn |
| 9 | Abivax | 90.15 Bn | 90.15 Bn | - |
| 10 | Enanta Pharmaceuticals | 343.24 Mn | 179.46 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | 200,000.00 |
| Jun 30, 2019 | 224,000.00 |
| Mar 31, 2019 | 249,000.00 |
| Dec 31, 2018 | 271,000.00 |
| Sep 30, 2018 | 293,000.00 |
| Jun 30, 2018 | 315,000.00 |
| Mar 31, 2018 | 337,000.00 |
| Dec 31, 2017 | 358,000.00 |
| Sep 30, 2017 | 379,000.00 |
| Jun 30, 2017 | 402,000.00 |
| Mar 31, 2017 | 421,000.00 |
| Dec 31, 2016 | 440,000.00 |
| Sep 30, 2016 | 458,000.00 |
| Jun 30, 2016 | 478,000.00 |
| Mar 31, 2016 | 513,000.00 |
| Dec 31, 2015 | 513,000.00 |
| Sep 30, 2015 | 529,000.00 |
| Jun 30, 2015 | 175,000.00 |